Affymax, Inc. (AFFY) Announces Proposed Public Offering of Common Stock
11/19/2009 9:17:08 AM
More...
|
Affymax, Inc. (AFFY) Prices Public Offering of Common Stock
11/19/2009 8:10:15 AM
More...
|
Affymax, Inc. (AFFY) Announces Completion of Final Scheduled Data Monitoring Committee Review of Phase 3 Hematide Program
11/10/2009 9:31:36 AM
More...
|
Affymax, Inc. (AFFY) and Takeda Global Research & Development Center, Inc. Announce Hematide(TM) Publication in the The New England Journal of Medicine
11/5/2009 10:05:45 AM
More...
|
Affymax, Inc. (AFFY) and Takeda Pharmaceutical Co. Ltd. (TKDG.DE) (JOBS) Phase 2 Data of Investigational Drug, Hematide, Suggest Its Ability to Restore Hemoglobin in Patients With Pure Red Cell Aplasia
11/5/2009 7:55:07 AM
More...
|
Affymax, Inc. (AFFY) Reports Third Quarter 2009 Financial Results
11/4/2009 9:29:07 AM
More...
|
Affymax, Inc. (AFFY) Names Hollings C. Renton Chairman of the Board of Directors
11/3/2009 8:39:14 AM
More...
|
Affymax, Inc. (AFFY) and Takeda Global Research & Development Center, Inc. Announce Preliminary Phase 2 Data Demonstrated That Hematide(TM) Increased Hemoglobin in Dialysis Patients
10/30/2009 12:26:41 PM
More...
|
Affymax, Inc. (AFFY) to Highlight Hematide(TM) Data at the American Society of Nephrology Renal Week 2009
10/22/2009 9:12:16 AM
More...
|
Affymax, Inc. (AFFY) Secures $60 Million Issuer Managed Equity Facility with Azimuth Opportunity, Ltd.
9/25/2009 7:17:59 AM
More...
|
|